1334 related articles for article (PubMed ID: 29309541)
1. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
[TBL] [Abstract][Full Text] [Related]
2. Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
Brown EE; Rashidi-Ranjbar N; Caravaggio F; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Fischer CE; Flint A; Mah L; Herrmann N; Bowie CR; Voineskos AN; Graff-Guerrero A;
J Neuroimaging; 2019 Nov; 29(6):721-729. PubMed ID: 31270885
[TBL] [Abstract][Full Text] [Related]
3. Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts.
Dewenter A; Jacob MA; Cai M; Gesierich B; Hager P; Kopczak A; Biel D; Ewers M; Tuladhar AM; de Leeuw FE; Dichgans M; Franzmeier N; Duering M;
Brain; 2023 Feb; 146(2):678-689. PubMed ID: 35859352
[TBL] [Abstract][Full Text] [Related]
4. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
5. Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
Madhavan A; Schwarz CG; Duffy JR; Strand EA; Machulda MM; Drubach DA; Kantarci K; Przybelski SA; Reid RI; Senjem ML; Gunter JL; Apostolova LG; Lowe VJ; Petersen RC; Jack CR; Josephs KA; Whitwell JL
J Alzheimers Dis; 2016; 49(3):633-43. PubMed ID: 26484918
[TBL] [Abstract][Full Text] [Related]
6. White Matter Differences in Networks in Elders with Mild Cognitive Impairment and Alzheimer's Disease.
Yang FPG; Bal SS; Lee JF; Chen CC
Brain Connect; 2021 Apr; 11(3):180-188. PubMed ID: 32731749
[No Abstract] [Full Text] [Related]
7. Tract-based analysis of white matter degeneration in Alzheimer's disease.
Lee SH; Coutu JP; Wilkens P; Yendiki A; Rosas HD; Salat DH;
Neuroscience; 2015 Aug; 301():79-89. PubMed ID: 26026680
[TBL] [Abstract][Full Text] [Related]
8. Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment.
Canuet L; Pusil S; López ME; Bajo R; Pineda-Pardo JÁ; Cuesta P; Gálvez G; Gaztelu JM; Lourido D; García-Ribas G; Maestú F
J Neurosci; 2015 Jul; 35(28):10325-30. PubMed ID: 26180207
[TBL] [Abstract][Full Text] [Related]
9. Microstructural brain changes track cognitive decline in mild cognitive impairment.
Reas ET; Hagler DJ; White NS; Kuperman JM; Bartsch H; Wierenga CE; Galasko D; Brewer JB; Dale AM; McEvoy LK
Neuroimage Clin; 2018; 20():883-891. PubMed ID: 30290303
[TBL] [Abstract][Full Text] [Related]
10. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
[TBL] [Abstract][Full Text] [Related]
11. Multivariate statistical analysis of diffusion imaging parameters using partial least squares: Application to white matter variations in Alzheimer's disease.
Konukoglu E; Coutu JP; Salat DH; Fischl B;
Neuroimage; 2016 Jul; 134():573-586. PubMed ID: 27103138
[TBL] [Abstract][Full Text] [Related]
12. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
13. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
14. Characterization of white matter changes along fibers by automated fiber quantification in the early stages of Alzheimer's disease.
Zhang X; Sun Y; Li W; Liu B; Wu W; Zhao H; Liu R; Zhang Y; Yin Z; Yu T; Qing Z; Zhu B; Xu Y; Nedelska Z; Hort J; Zhang B;
Neuroimage Clin; 2019; 22():101723. PubMed ID: 30798166
[TBL] [Abstract][Full Text] [Related]
15. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition.
Raghavan S; Przybelski SA; Reid RI; Lesnick TG; Ramanan VK; Botha H; Matchett BJ; Murray ME; Reichard RR; Knopman DS; Graff-Radford J; Jones DT; Lowe VJ; Mielke MM; Machulda MM; Petersen RC; Kantarci K; Whitwell JL; Josephs KA; Jack CR; Vemuri P
Acta Neuropathol Commun; 2022 Feb; 10(1):16. PubMed ID: 35123591
[TBL] [Abstract][Full Text] [Related]
16. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
17. Orientational changes of white matter fibers in Alzheimer's disease and amnestic mild cognitive impairment.
Zhao H; Cheng J; Liu T; Jiang J; Koch F; Sachdev PS; Basser PJ; Wen W;
Hum Brain Mapp; 2021 Nov; 42(16):5397-5408. PubMed ID: 34412149
[TBL] [Abstract][Full Text] [Related]
18. An advanced white matter tract analysis in frontotemporal dementia and early-onset Alzheimer's disease.
Daianu M; Mendez MF; Baboyan VG; Jin Y; Melrose RJ; Jimenez EE; Thompson PM
Brain Imaging Behav; 2016 Dec; 10(4):1038-1053. PubMed ID: 26515192
[TBL] [Abstract][Full Text] [Related]
19. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
20. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample.
Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA
Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
